KYMR Stock Summary and Trading Ideas (Kymera Therapeutics | NASDAQ:KYMR)

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Kymera Therapeutics trades on the NASDAQ stock market under the symbol KYMR.

As of March 3, 2025, KYMR stock price declined to $30.17 with 942,289 million shares trading.

KYMR has a beta of 2.25, meaning it tends to be more sensitive to market movements. KYMR has a correlation of 0.24 to the broad based SPY ETF.

KYMR has a market cap of $1.96 billion. This is considered a Small Cap stock.

Last quarter Kymera Therapeutics reported $7 million in Revenue and -$.88 earnings per share. This fell short of revenue expectation by $-7 million and missed earnings estimates by -$.09.

In the last 3 years, KYMR traded as high as $53.27 and as low as $9.60.

The top ETF exchange traded funds that KYMR belongs to (by Net Assets): VTI, VB, IWM, VXF, VBK.

KYMR has underperformed the market in the last year with a price return of -30.2% while the SPY ETF gained +16.7%. KYMR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -35.6% and -18.2%, respectively, while the SPY returned -2.2% and -4.3%, respectively.

KYMR support price is $30.15 and resistance is $32.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KYMR shares will trade within this expected range on the day.